Clinical Trial Update: Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

View source ↗

Summary

The study to evaluate real-world pharmacoeconomics of panitumumab in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: PeriPharm | Conditions: Colorectal Cancer Metastatic | Status: COMPLETED